MO
Matt O'Brien Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
3.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90%
Neutral
10%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Reiterated
| $1.25 |
9%
upside
| 1 | -22% |
–
| 14 Nov ‘25 19 days ago |
|
|
|
Overweight
Reiterated
| $18 |
18%
upside
| 1 | +12% |
0
%
| 12 Nov ‘25 21 days ago |
|
|
|
Overweight
Maintained
| $55 |
24%
upside
| 1 | -5.8% |
0
%
| 6 Nov ‘25 27 days ago |
|
|
|
Overweight
Reiterated
| $50 |
51%
upside
| 1 | -14% |
0
%
| 5 Nov ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $75 |
16%
upside
| 1 | -0.53% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $25 |
18%
upside
| 1 | +26% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $140 |
0%
downside
| 1 | +16% |
0
%
| 30 Oct ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $32 |
5%
upside
| 1 | +22% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $82 |
17%
upside
| 1 | -5.4% |
0
%
| 24 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $22 |
23%
upside
| 1 | -9.6% |
0
%
| 10 Oct ‘25 1 month ago |
|